“Investigator Global Assessment (IGA) of Actinic Keratosis (AK) Among Patients Administered Tirbanibulin in Real-World Community Practices across the U.S., and Clinician Likelihood to Consider Tirbanibulin Again for Future AK Treatments (PROAK Study)”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s162. Accessed May 17, 2025. https://skin.dermsquared.com/skin/article/view/2048.